These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2093532)

  • 21. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of recombinant erythropoietin with patients on programmed hemodialysis].
    Rozental' RL; Zezina LIu; Spudass AV
    Ter Arkh; 1991; 63(12):110-3. PubMed ID: 1803587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoietin-induced iritis-like reaction.
    Beiran I; Krasnitz I; Mezer E; Meyer E; Miller B
    Eur J Ophthalmol; 1996; 6(1):14-6. PubMed ID: 8744844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical studies of recombinant human erythropoietin in patients on long-term dialysis].
    Ji SM; Li LS; Ji DX
    Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):100-2. PubMed ID: 8404323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin.
    Haberl M
    Aust Nurses J; 1990 Sep; 20(2):29. PubMed ID: 2268202
    [No Abstract]   [Full Text] [Related]  

  • 27. Daily self-administered subcutaneous erythropoietin: benefits in haemodialysis patients.
    Granolleras C; Branger B; Deschodt G; Shaldon S; Nonnast-Daniel B; Pollok M
    Contrib Nephrol; 1990; 82():49-54. PubMed ID: 2093526
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of erythropoietin on the dialysis prescription.
    Van Wyck DB
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):71-5. PubMed ID: 1928083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment of anemia with low-dose recombinant human erythropoietin.
    Aronoff GR; Duff DR; Sloan RS; Brier ME; Maurice B; Erickson B; Golper TA
    Am J Nephrol; 1990; 10 Suppl 2():40-3. PubMed ID: 2260617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of recombinant human erythropoietin on hematological and hemostatic parameters with special reference to microhemolysis.
    Maurin N; Fitzner S; Fritz H; Gladziwa U; H agel J; Stefanidis I
    Clin Nephrol; 1995 Mar; 43(3):196-200. PubMed ID: 7774078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythropoietin use in peritoneal dialysis patients.
    Zimmerman SW; Johnson CA
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO).
    Campos A; Garin EH
    Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial.
    Beiraghdar F; Panahi Y; Einollahi B; Nemati E; Ghadiani MH; Sahebkar A; Maghsoudi N; Marzony ET
    Clin Lab; 2012; 58(7-8):737-45. PubMed ID: 22997974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability.
    Johnson WJ; McCarthy JT; Yanagihara T; Osmundson PJ; Ilstrup DM; Jenson BM; Bowie EJ
    Kidney Int; 1990 Nov; 38(5):919-24. PubMed ID: 2266676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics.
    Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M
    Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose recombinant human erythropoietin therapy in chronic hemodialysis patients.
    Duff DR; Golper TA; Sloan RS; Brier ME; Aronoff GR
    Am J Kidney Dis; 1991 Jul; 18(1):60-4. PubMed ID: 2063856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reticulocyte count used to assess recombinant human erythropoietin sensitivity in hemodialysis patients.
    Tatsumi N; Kojima K; Tsuda I; Yamagami S; Itoh Y; Tanaka H
    Contrib Nephrol; 1990; 82():41-8. PubMed ID: 2093525
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical experience with recombinant human erythropoietin in hemodialysis patients.
    Schaefer RM; Kuerner B; Zech M; Heidland A
    Pol Arch Med Wewn; 1988 Oct; 80(4):213-20. PubMed ID: 3078210
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
    Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
    BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.